Follow us on Twitter

Get News Alerts

Monday, November 13, 2017

Secondary CANTOS Analysis IDs Canakinumab Responders

  1. Secondary CANTOS Analysis IDs Canakinumab Responders  Medscape
  2. Novartis launches heart drug counter-offensive  Reuters
  3. AHA: CANTOS Substudy Supports Major Role of Inflammation  MedPage TodayFull coverage

No comments:

Post a Comment

Headlines